CRISABOROLE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 125 adverse event reports in the FDA FAERS database where CRISABOROLE was used for Psoriasis.
Most Reported Side Effects for CRISABOROLE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 1,815 | 23.3% | 1 | 6 |
| Application site pain | 1,414 | 18.2% | 2 | 5 |
| Burning sensation | 975 | 12.5% | 2 | 2 |
| Off label use | 673 | 8.7% | 4 | 11 |
| Condition aggravated | 613 | 7.9% | 2 | 12 |
| Pain | 468 | 6.0% | 0 | 2 |
| Pruritus | 378 | 4.9% | 2 | 4 |
| Rash | 342 | 4.4% | 0 | 5 |
| Eczema | 308 | 4.0% | 0 | 6 |
| Erythema | 285 | 3.7% | 1 | 5 |
| Product use in unapproved indication | 242 | 3.1% | 0 | 1 |
| Application site erythema | 234 | 3.0% | 0 | 1 |
| Drug hypersensitivity | 234 | 3.0% | 0 | 1 |
| Drug ineffective for unapproved indication | 230 | 3.0% | 1 | 5 |
| Skin burning sensation | 214 | 2.8% | 0 | 0 |
Other Indications for CRISABOROLE
Dermatitis atopic (2,139)
Eczema (1,292)
Dermatitis (407)
Rash (220)
Pruritus (123)
Dermatitis contact (92)
Dermatitis allergic (82)
Seborrhoeic dermatitis (44)
Erythema (42)
Product used for unknown indication (38)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)